Page last updated: 2024-10-30

mazindol and Amentia

mazindol has been researched along with Amentia in 1 studies

Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.

Research Excerpts

ExcerptRelevanceReference
"Distinguishing Alzheimer's disease from DLB is clinically relevant in terms of prognosis and appropriate treatment."1.30Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. ( Ballard, C; Burn, D; Court, JA; Jaros, E; Johnson, M; Lloyd, S; Marshall, EF; McKeith, IG; Perry, EK; Perry, RH; Piggott, MA; Thomas, N, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piggott, MA1
Marshall, EF1
Thomas, N1
Lloyd, S1
Court, JA1
Jaros, E1
Burn, D1
Johnson, M1
Perry, RH1
McKeith, IG1
Ballard, C1
Perry, EK1

Other Studies

1 other study available for mazindol and Amentia

ArticleYear
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Brain : a journal of neurology, 1999, Volume: 122 ( Pt 8)

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Corpus Striatum; Dementia; Dopamine; Fe

1999